Published: Jul 12, 2026
Written by Klarity Editorial Team
Published: Jul 12, 2026

If you’re a psychiatrist scrolling through patient messages and noticing yet another ‘I gained 40 pounds on my mood stabilizer—can you help?’ inquiry, you’re not alone. Or maybe you’ve seen the headlines about Ozempic and Wegovy and wondered: Could I add weight management to my practice?
Short answer: Yes. And the timing couldn’t be better.
By 2025, an estimated 6% of Americans (roughly 20 million people) were taking GLP-1 medications like semaglutide or tirzepatide—a staggering 600% increase in weight-loss usage over just six years. That’s not a trend. That’s a tidal wave of patient demand crashing into a healthcare system that doesn’t have nearly enough providers to meet it.
Here’s what makes this opportunity particularly relevant for psychiatrists: you’re already sitting at the intersection of mental health and metabolic health. Many of your patients struggle with medication-induced weight gain. You understand behavior change, motivation, and the psychological barriers to weight loss better than most providers. And unlike a typical weight-loss clinic, you can monitor mood effects, screen for binge eating, and provide integrated care that addresses the whole person.
But here’s the catch: scaling a GLP-1 practice while maintaining your sanity requires strategy. This isn’t about cramming more patients into your schedule until you burn out. It’s about building efficient systems, understanding the regulatory landscape, and creating sustainable workflows that let you meet demand without sacrificing your quality of life.
Let’s talk about how to actually do this—from acquiring your first GLP-1 patients to building a practice that scales without destroying your work-life balance.
Nearly half of psychiatrists surveyed in late 2023 reported they were already prescribing or recommending GLP-1 medications. Not because they suddenly pivoted to obesity medicine, but because their patients needed it.
Think about your caseload right now:
You’re probably already having these conversations. The question is whether you’re equipped to offer a solution beyond ‘talk to your primary care doctor’ (who may or may not have bandwidth, may or may not be comfortable prescribing, and almost certainly won’t address the mental health component).
Unlike a nurse practitioner running a cash-pay weight-loss mill or a primary care doctor squeezing GLP-1 consults between strep throat visits, you bring something valuable to the table: expertise in behavior change and mental health.
Weight loss isn’t just about the medication. Patients need help managing the psychological aspects:
Some early research even suggests GLP-1s might independently improve certain psychiatric symptoms in depression and bipolar disorder. While we’re still learning about these effects, psychiatrists are in the best position to monitor them.
Plus, you already have telehealth infrastructure and experience with chronic medication management. You know how to titrate doses, manage side effects, and maintain long-term patient relationships. These are the exact skills GLP-1 management requires.
Let’s address the elephant in the room: patient acquisition cost.
You’ve probably seen ads promising you can ‘acquire patients for $30-50’ through smart marketing. That’s bullshit. The reality of acquiring a qualified psychiatric or weight-loss patient through DIY marketing typically costs $200-500+ per patient when you factor in all the costs:
Google Ads for ‘weight loss doctor near me’ or ‘GLP-1 prescriber’ are expensive, and most clicks don’t convert to booked patients. SEO takes 6-12 months of consistent content creation and link building before it generates real patient flow—and that assumes you know what you’re doing (or pay someone who does).
Directory listings like Psychology Today or Zocdoc charge monthly subscription fees ($100-300+) and then you’re competing with hundreds of other providers on the same page. Zocdoc charges $35-100+ per booking on top of the subscription. It adds up fast.
Here’s the better math: instead of gambling $3,000-5,000 per month on marketing channels with uncertain ROI, consider platforms that use a pay-per-appointment model.
Platforms like Klarity Health handle patient acquisition for you:
This is guaranteed ROI versus gambling on whether your Google Ads campaign will work. You’re not paying for clicks that don’t convert or wasting months on SEO that may never rank. You’re paying only when a qualified patient books with you.
But before you even think about external marketing, start with your existing patients. This is the lowest-hanging fruit:
Identify candidates in your current caseload:
During your next medication review, simply bring it up: ‘I’ve been noticing you’ve mentioned weight gain as a concern. I’m now offering medical weight management with GLP-1 medications as part of our practice. Would you be interested in learning more?’
Many patients will say yes immediately. You’ve just converted an existing relationship into a new service line with zero marketing cost.
Once you’ve optimized your internal referral flow, consider these channels:
Referral Relationships:
Digital Presence:
Telehealth Platforms:
The key is consistency without overextension. Start small, refine your workflow, then scale.
Let’s cut through the confusion about prescribing GLP-1s via telehealth.
Unlike stimulants or benzodiazepines, GLP-1 medications are not scheduled drugs. This means:
The standard of care still applies—you need to conduct a thorough evaluation, obtain informed consent, document appropriately—but you can do all of this via video consult.
This is the iron-clad rule: you must hold an active medical license in the state where the patient is physically located at the time of the telemedicine visit.
For Psychiatrists (MD/DO):
For Psychiatric Nurse Practitioners (PMHNPs):This is where it gets state-specific and complicated. Let me break down the key states:
| State | PMHNP Requirements |
|---|---|
| California | Must work under physician supervision until 2026, when experienced NPs can become independent ‘104 NPs’ (after 3 years as supervised ‘103 NPs’). Not in IMLC. |
| Texas | Strict collaboration required—must have Prescriptive Authority Agreement with a Texas physician. Cannot practice independently. Texas is in IMLC (for physicians). |
| Florida | Must have physician protocol. Only primary care NPs (not psych) can achieve autonomous practice. Out-of-state telehealth registration available for MDs. |
| New York | Experienced NPs can practice independently after 3,600 hours. Newer NPs need physician collaboration. Not in IMLC. |
| Pennsylvania | Full collaboration required—all NPs need physician agreement. No independent practice. Pennsylvania is in IMLC (for physicians). |
| Illinois | Partial independence—NPs can achieve Full Practice Authority after 4,000 hours + 250 hours additional education. Illinois is in IMLC. |
Bottom line: If you’re a psychiatrist, you’re good to go in any state where you’re licensed. If you’re a PMHNP, you’ll need to either:
Many GLP-1 prescriptions for weight loss are technically off-label (e.g., using Ozempic instead of Wegovy, or prescribing to someone who doesn’t meet the exact FDA-approved BMI thresholds).
Off-label prescribing is legal and common—but you need to:
Rule out contraindications:
Get baseline labs: A1c, fasting glucose, liver panel, lipid panel, TSH if indicated.
You’ve probably seen the headlines about GLP-1s and suicide risk. Here’s what you need to know:
In late 2023, there were reports of rare suicidal ideation possibly linked to GLP-1 medications, prompting FDA investigations. By early 2026, the FDA reviewed the data and found no clear causal link, even directing removal of suicide warnings from GLP-1 labels.
That said, as a psychiatrist, you should:
This is actually an area where psychiatrists have a clinical advantage—you’re better equipped than a weight-loss clinic NP to catch and manage any psychiatric symptoms that emerge.
Here’s where most providers go wrong: they add GLP-1 services to their schedule without changing anything about their workflow, get overwhelmed by volume, and either quit or become miserable.
Don’t be that provider. Here’s how to scale sustainably:
Streamline Before You Scale:
Create digital intake forms that gather comprehensive history before the first appointment
Weight history and prior weight loss attempts
Current medications and medical conditions
Diet, exercise, and eating patterns
Mental health screening (PHQ-9, binge eating assessment)
Specific contraindications for GLP-1s
Develop standardized order sets for baseline labs
Create inclusion/exclusion criteria checklist
Use templated consent forms and patient education materials
This front-end efficiency saves 10-15 minutes per initial consult. Multiply that by 50 patients and you’ve saved 8-10 hours of appointment time.
Initial Phase (Months 1-3):
Maintenance Phase (After Month 3):
Use Technology:
This lets you monitor a large panel without needing to see everyone every month once they’re stable.
You don’t need to do everything yourself:
What Staff Can Handle:
What You Should Focus On:
Consider Team-Based Models:
Schedule Design:
Communication Boundaries:
Professional Development:
Monitor Your Own Burnout Signs:
If you notice these, it’s time to reassess workload, delegate more, or temporarily cap new patients.
Cash-Pay Model (Most Common for Weight Loss Telehealth):
Insurance Model:
Hybrid Approach (Recommended):
Note: Medicare announced plans to pilot weight-loss drug coverage starting in late 2025—if this expands, insurance-based models may become more viable.
Week 1 of New Patient:
Month 1 Follow-Up:
Months 3-6:
Group Support (Optional but Recommended):
This workflow lets you manage 100+ active GLP-1 patients without overwhelming your schedule.
Since telehealth rules vary by state, here’s what matters most for the six priority states:
California:
Texas:
Florida:
New York:
Pennsylvania:
Illinois:
The GLP-1 market is booming, but it won’t stay wide open forever. Right now, patient demand far outstrips provider supply. You can build a meaningful practice serving an underserved need while creating a new revenue stream.
But the key word is build. This isn’t about cramming more patients into an already-full schedule. It’s about creating efficient systems, leveraging technology and delegation, and maintaining boundaries that protect your well-being.
The psychiatrists who succeed in this space will be the ones who:
You have a unique advantage in this market. You understand the psychology of behavior change. You can manage the mental health aspects of weight loss. You’re comfortable with chronic medication management. You’re already set up for telehealth.
The question isn’t whether you can do this. It’s whether you’re willing to build the infrastructure to do it sustainably.
Ready to explore how Klarity Health can connect you with qualified GLP-1 patients without the marketing headache? Join our provider network to get pre-matched patients, built-in telehealth infrastructure, and a pay-per-appointment model that removes all the financial risk of patient acquisition. You focus on patient care; we handle everything else.
Do I need special training to prescribe GLP-1 medications?No special certification is required. As a licensed physician or NP (where allowed), you can prescribe GLP-1s within your scope of practice. That said, taking obesity medicine CME or obtaining an obesity medicine certification can boost your confidence and clinical skills. Understanding basic obesity management—nutrition principles, behavioral counseling, contraindications—is essential.
Can I prescribe GLP-1s via telehealth without ever meeting a patient in person?Yes. GLP-1 medications are not controlled substances, so the Ryan Haight Act doesn’t apply. You can establish a valid patient-provider relationship via video consult and prescribe entirely through telehealth, as long as you meet the standard of care (thorough evaluation, informed consent, appropriate documentation). State-specific telehealth rules still apply, but no state requires an in-person visit specifically for GLP-1 prescribing.
What about compounded semaglutide—is that legal?Yes, compounded semaglutide from licensed compounding pharmacies is legal and commonly used in telehealth weight-loss practices (especially when brand-name drugs are cost-prohibitive or in shortage). However, the FDA has issued warnings about unregulated or questionable compounders. Only work with reputable, licensed compounding pharmacies that use FDA-compliant ingredients. Inform patients they’re receiving a compounded medication and document this.
How do I handle insurance coverage for GLP-1s?Insurance coverage for GLP-1s for weight loss is limited. Most insurers cover them for diabetes but exclude obesity treatment. As of 2024, only 13 state Medicaid programs (including CA, PA, and IL) covered GLP-1s for weight loss. Medicare doesn’t currently cover them broadly but may start pilot programs. For patients whose insurance denies coverage, set expectations early about out-of-pocket costs. Many patients are prepared to pay cash for medications, especially if you offer competitive pricing through compounded alternatives.
How should I price my services?Cash-pay models typically charge $200-400 for an initial comprehensive evaluation and $100-200 for follow-ups. Some practices offer monthly memberships ($300-600) that bundle consultations, medication, and support. For insurance, you can bill standard E/M codes (99213/99214) or obesity counseling codes (G0447 for Medicare). Pricing should reflect your time, expertise, and the value of integrated mental health support.
What if a patient develops mood changes or reports suicidal thoughts?This is where your psychiatric expertise is invaluable. The FDA found no clear causal link between GLP-1s and suicidality, but individual cases can occur (and may be unrelated to the medication). Conduct thorough baseline mental health screening, monitor mood at every follow-up, and have a clear safety protocol. Document all assessments and interventions. If a patient develops concerning symptoms, adjust or discontinue the medication and provide appropriate psychiatric care.
How can I prevent burnout while scaling a GLP-1 practice?Start small and optimize before scaling. Use digital intake forms, standardized protocols, and templated documentation. Delegate non-specialist tasks to staff. Consider team-based care (health coaches, group sessions). Use technology (apps, remote monitoring) to reduce manual work. Set clear boundaries on appointment volume and communication hours. Monitor your own well-being and adjust workload before burnout hits.
What’s the best way to acquire GLP-1 patients cost-effectively?Start with your existing patient base—identify candidates and offer the service during routine visits (zero marketing cost). For external patient acquisition, platforms like Klarity Health offer pay-per-appointment models where you pay only when a pre-qualified patient books with you (no upfront marketing spend or monthly subscriptions). This eliminates the financial risk of traditional marketing channels where you might spend $3,000-5,000/month on ads, SEO, or directories with uncertain ROI.
Axios. ‘Just how many Americans are taking GLP-1s now.’ May 27, 2025. https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing
ConfectioneryNews. ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry.’ October 20, 2025. https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/
Time. ‘The Heavy Cost of Using Weight-Loss Drugs to Get Skinny.’ August 22, 2025. https://time.com/7311517/cost-weight-loss-drugs-skinny/
Axios. ‘America’s doctors need more obesity medicine training.’ May 28, 2024. https://www.axios.com/2024/05/28/us-doctors-obesity-health-care-training
Axios. ‘States slow to cover GLP-1s for weight loss.’ November 5, 2024. https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss
Find the right provider for your needs — select your state to find expert care near you.